The feasibility of collecting social determinants of health in the national multi-center GRASP sickle cell gene therapy trial

Authors: Colleen Kelly, Morgan Paul, Wendy London, Rahela Aziz-Bose, Puja Umaretiya, Erica Esrick, Victoria Coleman-Cowger, Gary Schiller, Mehrdad Abedi, Joseph Antin, Mary Horowitz, Neena Kapoor, Edmund Waller, Sonali Chaudhury, Mary Eapen, Mark Walters, David Williams, Kira Bona

Published: November 3, 2025

Click Here to Read More
Previous
Previous

Apheresis blood processing with heparin improves stem cell collection outcomes for sickle cell gene therapy

Next
Next

Improved hematopoietic stem cell mobilization for gene therapy using single agent motixafortide in sickle cell disease